Mastino A - Search Results

1

Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.

Matteucci C, Minutolo A, Sinibaldi-Vallebona P, Palamara AT, Rasi G, Mastino A, Garaci E. Matteucci C, et al. Among authors: mastino a. Ann N Y Acad Sci. 2010 Apr;1194:6-19. doi: 10.1111/j.1749-6632.2010.05484.x. Ann N Y Acad Sci. 2010. PMID: 20536445 Review.

2

Induction of apoptosis in thymocytes by prostaglandin E2 in vivo.

Mastino A, Piacentini M, Grelli S, Favalli C, Autuori F, Tentori L, Oliverio S, Garaci E. Mastino A, et al. Dev Immunol. 1992;2(4):263-71. doi: 10.1155/1992/80863. Dev Immunol. 1992. PMID: 1364176 Free PMC article.

3

Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.

Mastino A, Favalli C, Grelli S, Rasi G, Pica F, Goldstein AL, Garaci E. Mastino A, et al. Int J Cancer. 1992 Feb 1;50(3):493-9. doi: 10.1002/ijc.2910500327. Int J Cancer. 1992. PMID: 1735618

4

Effect of di-M-PGE2 on T cell differentiation. Flow cytometry study at thymus level.

Mastino A, Grelli S, Favalli C, Garaci E. Mastino A, et al. Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:851-4. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1825425 No abstract available.

5

Interaction between thymic hormones and other immunomodulatory agents.

Mastino A, Favalli C, Grelli S, Garaci E. Mastino A, et al. Ann Ist Super Sanita. 1991;27(1):51-6. Ann Ist Super Sanita. 1991. PMID: 1958028

6

Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.

Mastino A, Favalli C, Grelli S, Innocenti F, Garaci E. Mastino A, et al. Cell Immunol. 1991 Mar;133(1):196-205. doi: 10.1016/0008-8749(91)90191-d. Cell Immunol. 1991. PMID: 1991327

7

Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.

Garaci E, Mastino A, Pica F, Favalli C. Garaci E, et al. Among authors: mastino a. Cancer Immunol Immunother. 1990;32(3):154-60. doi: 10.1007/BF01771450. Cancer Immunol Immunother. 1990. PMID: 2126987 Free PMC article.

8

Enhanced immune response and antitumor immunity with combinations of biological response modifiers.

Garaci E, Mastino A, Favalli C. Garaci E, et al. Among authors: mastino a. Bull N Y Acad Med. 1989 Jan;65(1):111-9. Bull N Y Acad Med. 1989. PMID: 2481523 Free PMC article. Review.

9

Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice.

Favalli C, Mastino A, Jezzi T, Grelli S, Goldstein AL, Garaci E. Favalli C, et al. Among authors: mastino a. Int J Immunopharmacol. 1989;11(5):443-50. doi: 10.1016/0192-0561(89)90172-0. Int J Immunopharmacol. 1989. PMID: 2807622

10

Correlation between the effects of prostaglandins and interferon on B-16 melanoma growth and their modulation on natural killer activity.

Favalli C, Mastino A, Grelli S, Garaci E. Favalli C, et al. Among authors: mastino a. Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:159-62. Adv Prostaglandin Thromboxane Leukot Res. 1987. PMID: 2959042 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters